Skip to main content

Basile Edward M's Form 4 filing

TransMedics Group, Inc. (TMDX) · filed Aug 8, 2024

Accession no.
0000950170-24-094079
Filed
Aug 8, 2024
Trade date
Aug 6, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.01M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Basile Edward MCIK 0001773661Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 6, 2024Common StockMOption exerciseAcquired+6,750$28.12+$189,8107,482Direct
Aug 6, 2024Common StockSSaleDisposed−1,830$148.26−$271,315.85,652Direct
Aug 6, 2024Common StockSSaleDisposed−2,383$149.71−$356,758.933,269Direct
Aug 6, 2024Common StockSSaleDisposed−1,000$150.70−$150,7002,269Direct
Aug 6, 2024Common StockSSaleDisposed−1,537$151.89−$233,454.93732Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 6, 2024Common StockMOption exerciseDisposed−6,750$0.00$06,750Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)